Gestational Trophoblastic Tumours: An Update for 2014

[1]  T. Lawrie,et al.  First-line chemotherapy in low-risk gestational trophoblastic neoplasia. , 2016, The Cochrane database of systematic reviews.

[2]  A. Swerdlow,et al.  Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Tom Bourne,et al.  A missed opportunity for excellence: the NICE guideline on the diagnosis and initial management of ectopic pregnancy and miscarriage , 2014, Journal of Family Planning and Reproductive Health Care.

[4]  M. Seckl,et al.  Effect of early pregnancy following chemotherapy on disease relapse and fetal outcome in women treated for gestational trophoblastic neoplasia. , 2014, The Journal of reproductive medicine.

[5]  N. Sebire,et al.  Histopathological and immunohistochemical features of early hydatidiform mole in relation to subsequent development of persistent gestational trophoblastic disease. , 2014, The Journal of reproductive medicine.

[6]  E. Kohorn.  Worldwide survey of the results of treating gestational trophoblastic disease. , 2014, The Journal of reproductive medicine.

[7]  N. Sebire,et al.  Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010. , 2014, The Journal of reproductive medicine.

[8]  N. Sebire,et al.  Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Jing Zhang,et al.  Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour. , 2013, The Cochrane database of systematic reviews.

[10]  N. Sebire,et al.  EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Sebire,et al.  Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009 , 2012, British Journal of Cancer.

[12]  E. Chapman-Davis,et al.  Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia. , 2012, The Journal of reproductive medicine.

[13]  F. Sweep,et al.  Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. , 2012, Gynecologic oncology.

[14]  M. Seckl,et al.  Survival of women with gestational trophoblastic neoplasia and liver metastases: is it improving? , 2012, The Journal of reproductive medicine.

[15]  A. Lim,et al.  Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia , 2012, British Journal of Cancer.

[16]  R. Agarwal,et al.  Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study , 2012, The Lancet.

[17]  T. Lawrie,et al.  First-line chemotherapy in low-risk gestational trophoblastic neoplasia. , 2012, The Cochrane database of systematic reviews.

[18]  N. Sebire,et al.  What a difference an egg makes , 2011, The Lancet.

[19]  N. Sebire,et al.  Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study , 2009, The Lancet.

[20]  Y. Xiang,et al.  Changes of clinical features in hydatidiform mole: analysis of 113 cases. , 2008, The Journal of reproductive medicine.

[21]  N. Sebire,et al.  The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies. , 2007, Gynecologic oncology.

[22]  M. Seckl,et al.  Gestational trophoblastic neoplasia management: an update , 2007, Current opinion in oncology.

[23]  N. Sebire,et al.  Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit , 2007, BJOG : an international journal of obstetrics and gynaecology.

[24]  T. Powles,et al.  A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia , 2007, British Journal of Cancer.

[25]  N. Sebire,et al.  Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[26]  R. Berkowitz,et al.  Gestational Trophoblastic Disease , 1998, Clinical obstetrics and gynecology.

[27]  T. Powles,et al.  The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours , 2006, British Journal of Cancer.

[28]  N. Sebire,et al.  Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia. , 2006, The Journal of reproductive medicine.

[29]  B. Hancock,et al.  Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. , 2006, The Journal of reproductive medicine.

[30]  R. Kuick,et al.  Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans , 2006, Nature Genetics.

[31]  M. Seckl,et al.  High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia , 2005, British Journal of Cancer.

[32]  E. Jauniaux,et al.  A prospective study of ultrasound screening for molar pregnancies in missed miscarriages , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[33]  N. Sebire,et al.  Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin , 2002, The Lancet.

[34]  G. Rustin,et al.  Management of brain metastases in patients with high-risk gestational trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[35]  E. Kohorn.  Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. , 2002, The Journal of reproductive medicine.

[36]  G. Rustin,et al.  Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  M. Seckl,et al.  The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours , 2002, British Journal of Cancer.

[38]  N. Sebire,et al.  Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age , 2002, BJOG : an international journal of obstetrics and gynaecology.

[39]  FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee. , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[40]  M. Seckl,et al.  Choriocarcinoma and partial hydatidiform moles , 2000, The Lancet.

[41]  I. Shih,et al.  Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. , 1998, The American journal of surgical pathology.

[42]  R. Woolas,et al.  Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome , 1998, British journal of obstetrics and gynaecology.

[43]  G. Rustin,et al.  Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. , 1998, European journal of cancer.

[44]  E. Newlands,et al.  Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  N. Wake,et al.  Genetic origin of malignant trophoblastic neoplasms. , 1994, Cancer genetics and cytogenetics.

[46]  J. Palmer,et al.  Advances in the epidemiology of gestational trophoblastic disease. , 1994, The Journal of reproductive medicine.

[47]  H. Takamizawa,et al.  Genetic identification of pregnancies responsible for choriocarcinomas after multiple pregnancies by restriction fragment length polymorphism analysis. , 1991, American journal of obstetrics and gynecology.

[48]  S. Povey,et al.  Genetically homozygous choriocarcinoma following pregnancy with hydatidiform mole. , 1988, British Journal of Cancer.

[49]  K. Bagshawe,et al.  HYDATIDIFORM MOLE IN ENGLAND AND WALES 1973-83 , 1986, The Lancet.

[50]  G. Rustin,et al.  Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. , 1984, British medical journal.